You are here

  • Home
  • Archive
  • Volume 11, Issue 4
  • Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party

 

Online download statistics by month:

Online download statistics by month: April 2023 to January 2026

AbstractFullPdf
Apr 2023423420148
May 2023255257123
Jun 202318218267
Jul 202315615653
Aug 202317917937
Sep 202311811843
Oct 2023939332
Nov 2023999937
Dec 2023788140
Jan 2024818244
Feb 2024747438
Mar 202412112282
Apr 2024898950
May 2024585837
Jun 2024515130
Jul 2024828355
Aug 2024524923
Sep 2024727332
Oct 2024626227
Nov 2024414320
Dec 202410010126
Jan 2025636342
Feb 2025505025
Mar 2025727239
Apr 2025727532
May 2025444443
Jun 2025484823
Jul 2025110
Sep 2025550
Jan 2026001
Total282128301249